Willow Biosciences (TSX:WLLW) Total Liabilities : C$2.99 Mil (As of Dec. 2024)

View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences Total Liabilities?

Willow Biosciences's Total Liabilities for the quarter that ended in Dec. 2024 was C$2.99 Mil.

Willow Biosciences's quarterly Total Liabilities declined from Jun. 2024 (C$3.63 Mil) to Sep. 2024 (C$2.98 Mil) but then increased from Sep. 2024 (C$2.98 Mil) to Dec. 2024 (C$2.99 Mil).

Willow Biosciences's annual Total Liabilities increased from Dec. 2022 (C$1.77 Mil) to Dec. 2023 (C$3.24 Mil) but then declined from Dec. 2023 (C$3.24 Mil) to Dec. 2024 (C$2.99 Mil).

Willow Biosciences Total Liabilities Historical Data

The historical data trend for Willow Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Total Liabilities Chart

Willow Biosciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

22.42

5.33

1.77

3.24

2.99

Willow Biosciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															3.24	3.03	3.63	2.98	2.99

Willow Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Willow Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.993	+	(1.001	+	2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2.99

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2.489	-	-0.505
	=	2.99

Willow Biosciences's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.993	+	(1.001	+	2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	2.99

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	2.489	-	-0.505
	=	2.99

Willow Biosciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CANSF:USA 45CN:Germany

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Executives

Christopher Kenneth Savile	Director, Senior Officer
Travis Doupe	Senior Officer
Patricia Ranija Choudhary	Director
Sadiq Lalani	Director
Barbara Elaine Munroe	Director
Peter Seufer-wasserthal	Director
Trevor Anthony Peters	Director, Senior Officer
Troy Tapan Talkkari	Senior Officer

Willow Biosciences Headlines

No Headlines